SEI Investments’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12M | Sell |
690,897
-15,784
| -2% | -$216K | 0.01% | 1047 |
|
|
2026
Q1 | $8.78M | Buy |
706,681
+147,249
| +26% | +$1.98M | 0.01% | 1207 |
|
|
2025
Q4 | $7.05M | Buy |
559,432
+88,325
| +19% | +$1.01M | 0.01% | 1219 |
|
|
2025
Q3 | $4.72M | Buy |
471,107
+16,594
| +4% | +$149K | 0.01% | 1323 |
|
|
2025
Q2 | $3.68M | Buy |
454,513
+96,608
| +27% | +$728K | ﹤0.01% | 1391 |
|
|
2025
Q1 | $3M | Buy |
357,905
+18,444
| +5% | +$154K | ﹤0.01% | 1478 |
|
|
2024
Q4 | $2.69M | Buy |
339,461
+42,743
| +14% | +$359K | ﹤0.01% | 1564 |
|
|
2024
Q3 | $2.47M | Buy |
296,718
+169,618
| +133% | +$1.33M | ﹤0.01% | 1594 |
|
|
2024
Q2 | $807K | Buy |
127,100
+91,584
| +258% | +$581K | ﹤0.01% | 1985 |
|
|
2024
Q1 | $215K | Buy |
35,516
+11,534
| +48% | +$65K | ﹤0.01% | 2407 |
|
|
2023
Q4 | $146K | Buy |
23,982
+850
| +4% | +$3.79K | ﹤0.01% | 2482 |
|
|
2023
Q3 | $97.6K | Sell |
23,132
-6,232
| -21% | -$23.2K | ﹤0.01% | 2517 |
|
|
2023
Q2 | $91K | Buy |
29,364
+10,198
| +53% | +$21.7K | ﹤0.01% | 2578 |
|
|
2023
Q1 | $26.7K | Buy |
19,166
+2,572
| +15% | +$5.12K | ﹤0.01% | 2653 |
|
|
2022
Q4 | $33K | Sell |
16,594
-642
| -4% | -$1.44K | ﹤0.01% | 2498 |
|
|
2022
Q3 | $35K | Sell |
17,236
-726
| -4% | -$2.04K | ﹤0.01% | 2634 |
|
|
2022
Q2 | $36K | Sell |
17,962
-2,591
| -13% | -$9.39K | ﹤0.01% | 2620 |
|
|
2022
Q1 | $62K | Buy |
20,553
+3,096
| +18% | +$13.7K | ﹤0.01% | 2540 |
|
|
2021
Q4 | $58K | Sell |
17,457
-94,622
| -84% | -$472K | ﹤0.01% | 2567 |
|
|
2021
Q3 | $584K | Sell |
112,079
-10,751
| -9% | -$54.1K | ﹤0.01% | 2005 |
|
|
2021
Q2 | $616K | Buy |
122,830
+93,312
| +316% | +$530K | ﹤0.01% | 1990 |
|
|
2021
Q1 | $172K | Buy |
+29,518
| New | +$164K | ﹤0.01% | 2405 |
|
|
2020
Q4 | – | Sell |
-13,866
| Closed | -$51K | – | 2453 |
|
|
2020
Q3 | $51K | Sell |
13,866
-546
| -4% | -$2.33K | ﹤0.01% | 2373 |
|
|
2020
Q2 | $68K | Buy |
14,412
+350
| +2% | +$1.44K | ﹤0.01% | 2349 |
|
|
2020
Q1 | $45K | Buy |
14,062
+2,223
| +19% | +$9.41K | ﹤0.01% | 2307 |
|
|
2019
Q4 | $52K | Sell |
11,839
-2,401
| -17% | -$8.35K | ﹤0.01% | 2358 |
|
|
2019
Q3 | $37K | Buy |
14,240
+2,007
| +16% | +$7K | ﹤0.01% | 2355 |
|
|
2019
Q2 | $86K | Buy |
12,233
+4,710
| +63% | +$48.2K | ﹤0.01% | 2334 |
|
|
2019
Q1 | $116K | Buy |
7,523
+491
| +7% | +$6.49K | ﹤0.01% | 2451 |
|
|
2018
Q4 | $101K | Buy |
7,032
+1,028
| +17% | +$18.5K | ﹤0.01% | 2196 |
|
|
2018
Q3 | $134K | Sell |
6,004
-2,488
| -29% | -$52.4K | ﹤0.01% | 2017 |
|
|
2018
Q2 | $139K | Buy |
+8,492
| New | +$149K | ﹤0.01% | 2174 |
|
Other funds holding AMRX
TGA
RCMNY
SEI Investments's AMRX Position: Q2 2026 in Review
SEI Investments reduced its Amneal Pharmaceuticals (AMRX) stake by 2.2% in Q2 2026, selling an estimated $216K and leaving 690,897 shares worth $12M. The position accounts for 0.01% of the portfolio, ranked #1047.
SEI Investments first reported a position in AMRX in Q2 2018 and has held it in 32 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.
- SEI Investments held 690,897 shares of Amneal Pharmaceuticals worth $12M as of Q2 2026.
- SEI Investments sold 15,784 Amneal Pharmaceuticals shares in Q2 2026, an estimated $216K.
- Amneal Pharmaceuticals made up 0.01% of SEI Investments's portfolio in Q2 2026, its #1047 holding.
- SEI Investments first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 32 quarters since.
- 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.